Interpace Biosciences, Inc. (IDXG)

Market price: $5.50

6 valuation methods

• DCF (FCFF): $1.56 to $2.17 (midpoint $1.82)
• EV / Revenue: $1.71 to $3.63 (midpoint $2.20)
• EV / EBITDA: $2.02 to $5.36 (midpoint $2.89)
• P / B: $2.65 to $5.57 (midpoint $3.96)
• EV / Gross Profit: $2.24 to $7.76 (midpoint $4.06)
• P / E: $11.97 to $26.70 (midpoint $18.45)